Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ORAI1 modulators(Ca2+ release activated Ca2+ channel 1 modulators), STIM1 modulators(Stromal interaction molecule 1 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H22F3N5O4 |
InChIKeyZAJXAJYMOCWUGX-UHFFFAOYSA-N |
CAS Registry2169316-15-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Structural Myopathy | Preclinical | IT | ChemiCare SrlStartup | 16 May 2022 |
Congenital Structural Myopathy | Preclinical | IT | 16 May 2022 |